Novartis has issued price adjustments for Cafergot (ergotamine tartrate and caffeine), Cataflam (diclofenac potassium), Clozaril (clozapine), Combipatch (estradiol/norethindrone), Lamisil (terbinafme HCI), Sandostatin and Sandostatin LAR (octreotide acetate) Starlix (nateglinide) and Trileptal (oxcarbazepine).
Novartis also will discontinue the manufacture, distribution and sale of the pain killer Fioricet (butalbital/acetaminophen/caffine) tablets 100s (unit dose) and will discontinue the sale of angina treatment Transderm-Nitro (nitroglycerin transdermal) entirely. Novartis Pharmaceuticals Canada recalled the Transderm patch 0.4 in December after possible leakage of the nitroglycerin was reported. Antipsychotic drug Mellaril will be available ionlyn 50 mg tablets in 100 package units. For information on these changes, call Diane Staub at (973) 781-7726.
COPYRIGHT 2002 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2002 Gale Group
Home
A
Cabergoline
